Picture: msqrd2

The U.S. Drug Enforcement Administration desires to extend the quantity of marijuana produced for analysis subsequent yr – and by fairly a margin.

The DEA is proposing a lift from 2,450 kilograms in 2019 to three,200 kilograms in 2020. This yr’s stage was additionally fairly a leap on 2018, when it was simply 443 kilograms.

“This may meet the necessity created by the rise within the quantity of accepted analysis involving marijuana,” says an announcement from the Administration “Over the past two years, the overall variety of people registered by DEA to conduct analysis with marijuana, marijuana extracts, derivatives and delta-9-tetrahydrocannabinol (THC) has elevated by greater than 40 p.c, from 384 in January 2017 to 542 in January 2019.”

In different current cannabis information from the DEA, final month it introduced DEA registration would not be required to develop or manufacture sure sorts of cannabis, particularly hemp – nevertheless it received’t occur immediately. It additionally mentioned it might “facilitate and develop” scientific and medical marijuana analysis – and we see a sign of that with the announcement of proposed elevated manufacturing.

Nevertheless, the Scottsdale Analysis Institute (SRI) doesn’t seem like notably impressed with its efforts.

Whereas the DEA is getting with the instances considerably, it’s nonetheless persisting in referring to marijuana as “marihuana” in a few of its documentation. It appears continued use of the phrase has its roots within the Marihuana Tax Act of 1937, which was step one in the direction of prohibition within the USA.

On a associated notice, the DEA can also be proposing to cut back the quantity of sure opioids produced subsequent yr – fentanyl by 31 p.c, hydrocodone by 19 p.c, hydromorphone by 25 p.c, oxycodone by 9 p.c and oxymorphone by 55 p.c.

“Mixed with morphine, the proposed quota could be a 53 p.c lower within the quantity of allowable manufacturing of those opioids since 2016,” says the Administration.

The discount follows the enactment of the Substance Use-Dysfunction Prevention that Promotes Opioid Restoration and Therapy for Sufferers and Communities Act final yr (and sure, that’s the total title of the Act – you’ll be able to view it right here).

The prescription opioid epidemic has wreaked a really heavy toll within the USA. In keeping with the Nationwide Institute on Drug Abuse; prescription opioid overdose deaths rose from 3,442 in 1999 to 17,029 in 2017.

Along with the discount in manufacturing, cannabis has proven promise as a device in tackling the USA’s prescription opioid disaster.